Figure-2: Pre-treatment whole-body FDG-PET/CT (a,b,c) reveals asymmetrical increased activity mostly affecting the subcutaneous soft tissue of the left breast and axilla with hypermetabolic axillary lymph nodes (black arrows in a,b). Some patchy soft tissue activity also noted along the medial aspect of the right breast (yellow arrow in a). Follow-up whole-body FDG-PET/CT (d,e,f) reveals significantly decreased activity in the subcutaneous soft tissue of the left breast and axillary lymph nodes (black arrows in d,e). There is near complete resolution of the activity in the right breast.